Starting GLP-1 medications prematurely can cause increased nausea and vomiting, delayed gastric emptying, compromised nutritional intake, dehydration, and potentially delayed wound healing
The danger level depends on two things
The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin is released only when blood glucose levels are elevated, reducing hypoglycemia risk when used as monotherapy (though risk increases when combined with insulin or sulfonylureas)
How These Medications Work Our weight loss medications belong to a class known as GLP-1 receptor agonists , which help regulate appetite and support long-term weight management
It is for this reason we prefer the IV therapy, but may also supplement with glutathione pills
The Take-Away Its important to note that while many people report positive effects from MIC/B-12 injections, the evidence supporting these benefits is limited